Breaking News
Vance: Federal Government Has Identified $230 Billion In Fraud Since March
Saudi Arabia's $5 Oil Detour Is Expensive... But Worth It
Why Gen Z is the New Silent Generation
Can't come to Anarchapulco? Try Liberpulco
Top Tech News
What could possibly go wrong? Scientists use AI to design new viruses
Dual-motor suitcase drive underpins 3,000-hp hypercar
DoorDash Wins Federal Approval To Fly Its Own Delivery Drones
Shade-Resistant Solar Cells Retain 97% Efficiency After 2,000 Hours of Testing
20 Ancient Engineering SECRETS
Stonehenge Was Reanalyzed by AI -- And the Findings Are Hard to Explain
After Years Of Delays, Aptera Is Finally Preparing To Build Customer Cars
'When you kill it, it doesn't die': the jellyfish that has cracked the secret of immorta
Archer Aviation debuts Halo autonomous VTOL, Thunder's commercial twin
US Telecoms Slide On Starlink Mobile Threat; Bernstein Sees It As A "Jab, But No Knockout Yet**
Mice given dasatinib-quercitin lived 36% longer and in better health
A leukemia drug dasatinib and the dietary supplement quercetin reduced senescent cells' numbers, tamped down the inflammation they cause, and reduced the level of disability that comes with age-related diseases.
The drugs delayed age-related diseases. And the anti-aging effects of a single five-day course of the cocktail lasted for months, the equivalent in humans of more than a decade.
Giving dasatinib-quercitin combo in mice at the age equivalent of 75 to 90 years in humans let them live 36% longer with better physical function.